Dilip Doshi, the former Indian left-arm spinner, passed away in London due to cardiac arrest. He was 77. Doshi represented India in 33 Test...

The analyst suggested a stoploss at Rs 410 .

Despite challenges in locating premium real estate in tier 2 cities for expansion, Montblanc’s sales in smaller towns have been growing thr...

Lamy products will be imported from Germany and will be sold at price-tag starting Rs 900 onwards, said the company.

The former left-arm spinner talks about moving on and not holding on to negative emotions.

Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 634.0 and a stop loss at Rs 575 from entry point.

Buy Indo Count Industries Ltd. at a price target of Rs 135.0 and a stop loss at Rs 120 from entry point.

There was a previous distribution agreement with Entrack which has been properly cancelled quite a while ago.

The court, in its order also observed that arbitrators are free to interpret the ambit, scope and nature of the confidentiality concept.

"It's alright if we can't sell the product. But not being able to service existing customers of the brand is a major concern," said the sou...

Despite the legal battle brewing between Mont Blanc and Dilip Doshi, proprietor, Entrack International Trading, Mont Blanc's India operatio...

Doshi's Entrack Trading Company had a tie-up with Montblanc, and has now taken it to court and the case is pending in the Gujarat high cour...

Doshi, along with his four family members and his firm, had challenged Mont Blanc's move to change its marketing partner before a Rajkot ci...

Doshi was among the first to introduce luxury products into India in the early 1990s when he tied up with Montblanc to launch its range of ...

Organic Haus, an all-organic brand, said it was aiming to open up to 30 stores across the country in next two years.

Montblanc is evaluating steps to wrest control of its Indian operations from Dilip Doshi-promoted Entrack International, its Indian distrib...

Sun Pharmaceutical Industries' US-based subsidiary Caraco, which is facing a Food and Drug Administration ban on manufacturing, is looking ...